-
1.Reddy AR, Dinesh P, Prabhakar AS, Umasankar K, Shireesha B, Raju MB (2013) A comprehensive review on sar of curcumin. Mini Rev Med Chem 13:1769–1777
-
2.Reuter S, Eifes S, Dicato M, Aggarwal BB, Diederich M (2008) Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol 76:1340–1351
-
3.Reuter S, Charlet J, Juncker T, Teiten MH, Dicato M, Diederich M (2009) Effect of curcumin on nuclear factor kappab signaling pathways in human chronic myelogenous k562 leukemia cells. Ann N Y Acad Sci 1171:436–447
-
4.Teiten MH, Eifes S, Reuter S, Duvoix A, Dicato M, Diederich M (2009) Gene expression profiling related to anti-inflammatory properties of curcumin in k562 leukemia cells. Ann N Y Acad Sci 1171:391–398
-
5.Teiten MH, Eifes S, Dicato M, Diederich M (2010) Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins (Basel) 2:128–162
-
6.Teiten MH, Gaascht F, Cronauer M, Henry E, Dicato M, Diederich M (2011) Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the wingless signaling pathway. Int J Oncol 38:603–611
-
7.Teiten MH, Gaigneaux A, Chateauvieux S, Billing AM, Planchon S, Fack F, Renaut J, Mack F, Muller CP, Dicato M et al (2012) Identification of differentially expressed proteins in curcumin-treated prostate cancer cell lines. Omics 16:289–300
-
8.Teiten MH, Dicato M, Diederich M (2013) Curcumin as a regulator of epigenetic events. Mol Nutr Food Res 57:1619–1629
-
9.Teiten MH, Dicato M, Diederich M (2014) Hybrid curcumin compounds a new strategy for cancer treatment. Molecules 19:20839–20863